Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BRIAN D ARDEL

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1326081530
CMS profile
286330
Location
PORT CHARLOTTE, FL

General Payments · PY2018–2024

$16,092.41

  • Reported across 291 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$2,852.42

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,482.55 33
Travel and Lodging $369.87 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,161.70 35
PY2019 $3,231.24 57
PY2020 $2,194.88 66
PY2021 $2,028.22 44
PY2022 $1,804.74 27
PY2023 $1,819.21 27
PY2024 $2,852.42 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $146.54 12/12/2024 Food and Beverage Undisputed 01/23/2026 1124988704 CMS
ABBVIE INC. $105.54 11/04/2024 Food and Beverage Undisputed 01/23/2026 1103236971 CMS
Amgen Inc. $125.00 02/07/2024 Food and Beverage Undisputed 01/23/2026 1111518807 CMS
Amgen Inc. $124.99 02/21/2024 Food and Beverage Undisputed 01/23/2026 1111518809 CMS
Amgen Inc. $124.99 02/21/2024 Food and Beverage Undisputed 01/23/2026 1111518811 CMS
Amgen Inc. $22.14 07/29/2024 Food and Beverage Undisputed 01/23/2026 1117192173 CMS
Amgen Inc. $13.66 10/15/2024 Food and Beverage Undisputed 01/23/2026 1117192175 CMS
AstraZeneca Pharmaceuticals LP $126.37 02/13/2024 Food and Beverage Undisputed 01/23/2026 1104624406 CMS
AstraZeneca Pharmaceuticals LP $22.69 02/16/2024 Food and Beverage Undisputed 01/23/2026 1104530944 CMS
AstraZeneca Pharmaceuticals LP $124.99 05/01/2024 Food and Beverage Undisputed 01/23/2026 1104395219 CMS
AstraZeneca Pharmaceuticals LP $124.99 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104338916 CMS
AstraZeneca Pharmaceuticals LP $119.92 09/18/2024 Food and Beverage Undisputed 01/23/2026 1105505960 CMS
Azurity Pharmaceuticals, Inc. $19.54 08/20/2024 Food and Beverage Undisputed 01/23/2026 1134002550 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $112.49 04/11/2024 Food and Beverage Undisputed 01/23/2026 1117964056 CMS
Boston Scientific Corporation $32.00 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1092442008 CMS
Boston Scientific Corporation $96.39 03/01/2024 Food and Beverage Undisputed 01/23/2026 1092442010 CMS
Boston Scientific Corporation $337.87 03/01/2024 Travel and Lodging Undisputed 01/23/2026 1092442024 CMS
Boston Scientific Corporation $180.35 03/02/2024 Food and Beverage Undisputed 01/23/2026 1092442022 CMS
Boston Scientific Corporation $140.80 05/14/2024 Food and Beverage Undisputed 01/23/2026 1092442020 CMS
Esperion Therapeutics, Inc. $18.18 01/31/2024 Food and Beverage Undisputed 01/23/2026 1129426342 CMS
Esperion Therapeutics, Inc. $10.72 03/21/2024 Food and Beverage Undisputed 01/23/2026 1129426344 CMS
Esperion Therapeutics, Inc. $4.21 05/09/2024 Food and Beverage Undisputed 01/23/2026 1129426346 CMS
Esperion Therapeutics, Inc. $124.99 06/26/2024 Food and Beverage Undisputed 01/23/2026 1129426348 CMS
GlaxoSmithKline, LLC. $6.65 04/19/2024 Food and Beverage Undisputed 01/23/2026 1116574660 CMS
GlaxoSmithKline, LLC. $124.99 08/08/2024 Food and Beverage Undisputed 01/23/2026 1116288312 CMS
GlaxoSmithKline, LLC. $0.91 10/16/2024 Food and Beverage Undisputed 01/23/2026 1115970948 CMS
Janssen Pharmaceuticals, Inc $10.42 02/15/2024 Food and Beverage Undisputed 01/23/2026 1077975672 CMS
Janssen Pharmaceuticals, Inc $124.99 02/15/2024 Food and Beverage Undisputed 01/23/2026 1077975870 CMS
Janssen Pharmaceuticals, Inc $100.81 03/27/2024 Food and Beverage Undisputed 01/23/2026 1077975700 CMS
Lilly USA, LLC $19.26 02/01/2024 Food and Beverage Undisputed 01/23/2026 1136087530 CMS
Lilly USA, LLC $24.44 03/26/2024 Food and Beverage Undisputed 01/23/2026 1136022300 CMS
Novartis Pharmaceuticals Corporation $19.95 01/16/2024 Food and Beverage Undisputed 01/23/2026 1086691855 CMS
Novartis Pharmaceuticals Corporation $19.89 04/25/2024 Food and Beverage Undisputed 01/23/2026 1086691857 CMS
Phathom Pharmaceuticals, Inc. $124.99 09/12/2024 Food and Beverage Undisputed 01/23/2026 1151035955 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.76 01/11/2024 Food and Beverage Undisputed 01/23/2026 1153631070 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.